The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by de Haan, L.
* Articles by Booij, J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by de Haan, L.
* Articles by Booij, J.
Related Collections
* Neurotransmitters
* Schizophrenia Spectrum Disorders
* Antidepressants
Am J Psychiatry 157:1019-1020, June 2000
© 2000 American Psychiatric Association


Brief Report

Subjective Experience and Striatal Dopamine D2 Receptor Occupancy in Patients With Schizophrenia Stabilized by Olanzapine or Risperidone

Lieuwe de Haan, M.D., Jules Lavalaye, M.D., Don Linszen, M.D., Ph.D., Peter M.A.J. Dingemans, Ph.D., and Jan Booij, M.D., Ph.D.

OBJECTIVE: The authors’ goal was to study the relationship between subjective experience during treatment with olanzapine or risperidone and dopamine D2 receptor occupancy in stabilized patients with schizophrenia.METHOD: Subjective experience, psychopathology, and extrapyramidal symptoms were assessed, and D2 receptor occupancy was determined with [123I]iodobenzamide single photon emission computed tomography, in 22 patients whose schizophrenia was stabilized by olanzapine or risperidone.RESULTS: Subjective experience, depression, and negative symptoms were related to dopamine D2 receptor occupancy, but extrapyramidal symptoms were not.CONCLUSIONS: These results provide preliminary evidence that negative subjective experience is related to high D2 receptor occupancy. Longitudinal study is required because this relationship may have implications for dosing strategies.




This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
R. Mizrahi, P. Rusjan, O. Agid, A. Graff, D. C. Mamo, R. B. Zipursky, and S. Kapur
Adverse Subjective Experience With Antipsychotics and Its Relationship to Striatal and Extrastriatal D2 Receptors: a PET Study in Schizophrenia
Am J Psychiatry, April 1, 2007; 164(4): 630 - 637.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
C. Mohr, P. S. Sandor, T. Landis, M. Fathi, and P. Brugger
Blinking and schizotypal thinking
J Psychopharmacol, September 1, 2005; 19(5): 513 - 520.
[Abstract] [PDF]


Home page
Am. J. PsychiatryHome page
L. de HAAN, J. LAVALAYE, J. BOOIJ, and D. LINSZEN
Comfort, Self-Confidence, Safety, and Dopamine D2 Receptor Occupancy by Antipsychotics
Am J Psychiatry, August 1, 2005; 162(8): 1544 - 1545.
[Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
L. de Haan, M. van Bruggen, J. Lavalaye, J. Booij, P. M.A.J. Dingemans, and D. Linszen
Subjective Experience and D2 Receptor Occupancy in Patients With Recent-Onset Schizophrenia Treated With Low-Dose Olanzapine or Haloperidol: A Randomized, Double-Blind Study
Am J Psychiatry, February 1, 2003; 160(2): 303 - 309.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2000 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org